Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study. [electronic resource]
Producer: 20171010Description: 2058-2070.e1 p. digitalISSN:- 1879-114X
- Administration, Intravenous
- Adrenal Cortex Hormones -- therapeutic use
- Anti-Asthmatic Agents -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Asthma -- drug therapy
- Double-Blind Method
- Drug Administration Schedule
- Eosinophilia -- drug therapy
- Female
- Glucocorticoids -- administration & dosage
- Humans
- Injections, Subcutaneous
- Male
- Middle Aged
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.